These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3011322)

  • 1. Aging and vasodilation to atrial peptides.
    Emmick JT; Cohen ML
    Clin Exp Hypertens A; 1986; 8(1):75-90. PubMed ID: 3011322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity in responses of isolated monkey arteries and veins to atrial natriuretic peptide.
    Kawai Y; Ohhashi T
    Can J Physiol Pharmacol; 1989 Apr; 67(4):326-30. PubMed ID: 2527081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of age on relaxation of rat blood vessels to atriopeptin II.
    Duckles SP
    J Pharmacol Exp Ther; 1987 Mar; 240(3):697-700. PubMed ID: 2951516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic atrial natriuretic factor does not dilate resistance-sized arteries.
    Osol G; Halpern W; Tesfamariam B; Nakayama K; Weinberg D
    Hypertension; 1986 Jul; 8(7):606-10. PubMed ID: 2941373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial natriuretic peptide-induced relaxation of pre-constricted isolated rat perfused lungs: a comparison in control and hypoxia-adapted animals.
    Stewart AG; Thompson JS; Rogers TK; Morice AH
    Clin Sci (Lond); 1991 Aug; 81(2):201-8. PubMed ID: 1653664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial reactivity, blood pressure, and plasma levels of atrial natriuretic peptides in normotensive and hypertensive rats: effects of acute and chronic administration of atriopeptin III.
    De Mey JG; Defreyn G; Lenaers A; Calderon P; Roba J
    J Cardiovasc Pharmacol; 1987 May; 9(5):525-35. PubMed ID: 2439832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasorelaxant effects of and receptors for atrial natriuretic peptides in the mesenteric artery and aorta of the rat.
    St-Louis J; Schiffrin EL
    Can J Physiol Pharmacol; 1988 Jul; 66(7):951-6. PubMed ID: 2850846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relaxant effects of atrial natriuretic factor on vascular smooth muscle.
    Winquist RJ
    Life Sci; 1985 Sep; 37(12):1081-7. PubMed ID: 2863731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo atrial peptide-venodilation: minimal potency relative to nitroglycerin in dogs.
    Holtz J; Stewart DJ; Elsner D; Bassenge E
    Life Sci; 1986 Dec; 39(23):2177-84. PubMed ID: 2946916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible mechanisms underlying the vasorelaxant response to atrial natriuretic factor.
    Winquist RJ
    Fed Proc; 1986 Aug; 45(9):2371-5. PubMed ID: 3015691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relaxation Induced by Atrial Natriuretic Peptide Is Impaired in Carotid but Not Renal Arteries from Spontaneously Hypertensive Rats Due to Reduced BKCa Channel Activity.
    Matsumoto T; Watanabe S; Yamada K; Ando M; Iguchi M; Taguchi K; Kobayashi T
    Biol Pharm Bull; 2015; 38(11):1801-8. PubMed ID: 26521831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of calcitonin gene-related peptide (CGRP) on regional haemodynamics and on selected hepato-splanchnic arteries from the rat: a comparison with VIP and atriopeptin II.
    Bråtveit M; Haugan A; Helle KB
    Scand J Clin Lab Invest; 1991 Apr; 51(2):167-74. PubMed ID: 1828305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of atriopeptin II to cause arterial vasodilation in the conscious rat.
    Lappe RW; Smits JF; Todt JA; Debets JJ; Wendt RL
    Circ Res; 1985 Apr; 56(4):606-12. PubMed ID: 3156690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Action of C-type natriuretic peptide in isolated canine arteries and veins.
    Wei CM; Aarhus LL; Miller VM; Burnett JC
    Am J Physiol; 1993 Jan; 264(1 Pt 2):H71-3. PubMed ID: 8430863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related changes in relaxant response of vascular smooth muscles to atrial natriuretic peptide.
    Kawai Y; Ohhashi T
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1234-9. PubMed ID: 2138668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired vasorelaxant responses to natriuretic peptides in the stroke-prone phenotype of spontaneously hypertensive rats.
    Russo R; Vecchione C; Cosentino F; Natale A; Mele AF; Muscolo M; Savoia C; Ganten D; Rubattu S; Volpe M
    J Hypertens; 1998 Feb; 16(2):151-6. PubMed ID: 9535141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced dilatation by atrial natriuretic peptide of renal arcuate arteries from young, but not adult, spontaneously hypertensive rats.
    Mulvany MJ
    Clin Exp Hypertens A; 1987; 9(11):1789-801. PubMed ID: 2963713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasodilator responses to alpha-human-atrial natriuretic peptide in isolated omental and pulmonary arteries from rabbit and man.
    Lindberg F; Andersson KE
    Acta Physiol Scand; 1988 Nov; 134(3):391-7. PubMed ID: 2976241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular and vascular atrial natriuretic factor receptors in cardiomyopathic hamsters: correlation with the peptide biological effects.
    Cachofeiro V; Schiffrin EL; Cantin M; Garcia R
    Cardiovasc Res; 1990 Oct; 24(10):843-50. PubMed ID: 1964873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular atrial natriuretic factor receptors in spontaneously hypertensive rats.
    Schiffrin EL; Parent A; St Louis J; Tremblay J; Garcia R; Thibault G
    Cardiovasc Res; 1992 Sep; 26(9):857-64. PubMed ID: 1360334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.